ThomasWestoverMD
Obstetrics & Gynecology • Pennington, NJMaternal & Fetal Medicine/High Risk
Assistant Professor, Obstetrics and Gynecology, Cooper Medical School of Rowan Univ
Dr. Westover is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Capital Way
Pennington, NJ 08534Phone+1 609-537-7252Fax+1 609-537-6070
Education & Training
Rutgers Health/New Jersey Medical SchoolFellowship, Maternal-Fetal Medicine, 1992 - 1994- Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Obstetrics and Gynecology, 1988 - 1992
- Rutgers New Jersey Medical SchoolClass of 1988
Certifications & Licensure
NJ State Medical License 1989 - 2025
NY State Medical License 2023 - 2025
SD State Medical License Active through 2023
MN State Medical License 2017 - 2020
PA State Medical License 2006 - 2016
IL State Medical License 2007 - 2008
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Maternal-Fetal Medicine
Awards, Honors, & Recognition
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Non-invasive Test to Detect Intra-amniotic Infection in Women With Preterm Labor and Intact Amniotic Membranes Start of enrollment: 2008 Jun 01
Publications & Presentations
PubMed
- Fetal fraction amplification within prenatal cfDNA screening enables detection of genome-wide copy-number variants at enhanced resolution.Ashley Acevedo, Oyang Teng, Heather G LaBreche, Alison Nguyen, Luis Jazo
Genetics in Medicine. 2025-01-01 - Curation and reporting of pathogenic genome-wide copy-number variants in a prenatal cell-free DNA screen.Samuel G Cox, Ashley Acevedo, Anand Ahuja, Heather G LaBreche, Maria P Alfaro
Genetics in Medicine. 2025-01-01 - High positive predictive value 22q11.2 microdeletion screening by prenatal cell-free DNA testing that incorporates fetal fraction amplification.Carly Hammer, Summer Pierson, Ashley Acevedo, James Goldberg, Thomas Westover
Prenatal Diagnosis. 2024-07-01
Press Mentions
We’re ‘Thrilled’ Medicaid Will Provide More Help to New Moms. But More Is Needed. | OpinionNovember 11th, 2021
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
